Clinical Trials Browser

Phase 1/2 × Lymphoma × 1-dodecylpyridoxal × Clear all

NCT00785798 2022-04-04

Vorinostat and Pegylated Liposomal Doxorubicin in Relapsed or Refractory Lymphomas

Phase 1/2 Terminated

17 enrolled 4 charts

Lymphoma